Together, these findings support the view that although AMIGO family members may broadly modulate tumor biology, AMIGO2 is the dominant functional driver in pancreatic adenocarcinoma, likely through adhesion-related mechanisms. This evidence concerns the gene AMIGO2 and pancreatic adenocarcinoma.